Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003070901 | SCV003446109 | uncertain significance | not provided | 2023-06-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 2139722). This variant is present in population databases (rs61749581, gnomAD 0.005%). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 4984 of the HMCN1 protein (p.Leu4984Phe). |
Ambry Genetics | RCV004070200 | SCV003879990 | uncertain significance | not specified | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.14952G>C (p.L4984F) alteration is located in exon 96 (coding exon 96) of the HMCN1 gene. This alteration results from a G to C substitution at nucleotide position 14952, causing the leucine (L) at amino acid position 4984 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003456303 | SCV004180611 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |